Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling
Saved in:
Main Authors: | Bin Zhang, Jingyi Zhang, Chenyang Zhang, Xuelian Zhang, Jingxue Ye, Shihuan Kuang, Guibo Sun, Xiaobo Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1488083/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: D-dencichine regulates thrombopoiesis by promoting megakaryocyte adhesion, migration and proplatelet formation
by: Shilan Ding, et al.
Published: (2025-01-01) -
Research on TCN Model Based on SSARF Feature Selection in the Field of Human Behavior Recognition
by: Wei Zhang, et al.
Published: (2024-01-01) -
Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine
by: Bin Wan, et al.
Published: (2025-01-01) -
PEDF Overexpression Ameliorates Cardiac Lipotoxicity in Diabetic Cardiomyopathy via Regulation of Energy Metabolism
by: Mao T, et al.
Published: (2025-01-01) -
Sepsis subphenotypes: bridging the gaps in sepsis treatment strategies
by: Xue Zhang, et al.
Published: (2025-02-01)